Results of a study examing lenalidomide maintenance therapy after autologous stem cell transplant for treatment of non-Hodgkin lymphomas.
Home / Resource Library / Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study